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Scope: Probiotic interventions are known to have been shown to influence the
composition of the intestinal microbiota in geriatrics. The growing concern is the apparent
variation in response to identical strain dosage among human volunteers. One factor that
governs this variation is the host gut microbiome. In this study, we attempted to define a
core gut metagenome, which could act as a predisposition signature marker of inherent
bacterial community that can help predict the success of a probiotic intervention.
Methods and results: To characterize the geriatric gut microbiome, we designed primers
targeting the 16S rRNA hypervariable region V2–V3 followed by semiconductor sequenc-
ing using Ion Torrent PGM. Among respondents and non-respondents, the chief genera
of phylum Firmicutes that showed significant differences are Lactobacillus, Clostridium,
Eubacterium, and Blautia (q<0.002), while in the genera of phylum Proteobacteria
included Shigella, Escherichia, Burkholderia and Camphylobacter (q<0.002).
Conclusion: We have identified potential microbial biomarkers and taxonomic pat-
terns that correlate with a positive response to probiotic intervention in geriatric vol-
unteers. Future work with larger cohorts of geriatrics with diverse dietary influences
could reveal the potential of the signature patterns of microbiota for personalized
nutrition.
Keywords: geriatric, gut, metagenome, probiotics, MTCC 5463
Abbreviations: μl, microliter; AAU, Anand Agricultural University; CFU, colony forming unit; dL, deciliter; dNTP, deoxynu-
cleotide; ICMR, Indian Council of Medical Research; ISAPP, International Scientific Association for Probiotics and Prebiotics;
mg,milligram;ml,milliliter;mM,millimolar;MTCC,microbial type culture collection; nt, nucleotide; PGM, PersonalGenome
Machine; pmol, picomol; QIIME, Quantitative Insights intoMicrobial Ecology; rRNA, ribosomal RNA; s, seconds; S, Svedberg
unit; U, unit.
Frontiers in Microbiology | www.frontiersin.org September 2015 | Volume 6 | Article 9441
Senan et al. Geriatrics and the effect to probiotics
Introduction
An integrative study of the host and its surrounding environment
is imperative to comprehend the complex biological system of the
human body. As a part of the environment, the human host more
than 100 trillion bacteria forming the “in-vironment” (deWouters
et al., 2000)made up ofmillions ofmicrobial genes in the intestine
(Lederberg, 2000). The indigenous microbial community plays an
integral role in regulating the host’s physiological, nutritional, and
immunological processes (Hooper et al., 2001). The study of the
diversity of the indigenous microbial community can explain the
host microbe interaction (Gerritsen et al., 2011). The gut micro-
biota composition changes with age due to physiological reasons
and increased use of medications (Bartosch et al., 2004; Mueller
et al., 2006;Mariat et al., 2009; Zwielehner et al., 2009). Themicro-
biota of elderly people showed a higher Bacteroidetes/Firmicutes
ratio along with a high inter-individual variation in microbiota
composition at the phylum level when compared with young
adults (Claesson et al., 2011). Studies of the geriatric gut have
shown a decline in the count and diversity among Bacteroidetes
(Hopkins andMacfarlane, 2002;Woodmansey et al., 2004; Guigoz
et al., 2008). Proteolytic bacteria increase on aging in the large
bowel, leading to putrefaction (Hopkins et al., 2001). Such changes
in intestinal microbiome cause prolonged intestinal transit time
and fecal retention among geriatrics (Tiihonen et al., 2009). An
understanding of the changes in themicrobiome of the elderly has
led to the possibility of correcting the dysbiosis by administering
probiotics. Probiotics have been successful in increasing the levels
of health-promoting bacteria in the fecal microbiota of elderly
(Ahmed et al., 2007; Lahtinen et al., 2009; Matsumoto et al.,
2009), improving the frequency of bowel movements (Pitkala
et al., 2007), Clostridium difficile-associated diarrhea incidence
(Ouwehand et al., 2009), and frequency of defecation (An et al.,
2010).
The translation of the above-mentioned benefits of probiotics
to the host cannot be guaranteed. This could be due to the
individual differences with respect to diet, the structure and
operations of the gut microbiota, nutrient and energy harvest,
variations in human environmental exposures, microbial ecology,
and genotype (Turnbaugh et al., 2009). In order to assure uniform
outcomes of therapy among subjects, the International Scientific
Association for Probiotics and Prebiotics (ISAPP) had come up
with recommendations for conducting a well-defined trial (Reid
et al., 2010). Briefly, they include (1) clearly define the end goal, (2)
design the study by identifying precise parameters and defining
the level of response that will be tested, (3) base the selection of the
intervention on scientific investigations, and (4) carefully select
the study cohort. Inter-individual diversity in responses toward
probiotics could also be due to core gut microbiome patterns.
Recently, role of microbial biomarkers for determining dietary
responsiveness were identified in obese individuals (Korpela et al.,
2014) and metabolic diseases (McOrist et al., 2011; Walker et al.,
2011; Louis, 2012; Lampe et al., 2013), paving the way for per-
sonalized nutrition. This study takes up the challenge to identify
the factors that differentiate a respondent from a non-respondent
and utilize the findings to define the precise dose and response
prognosis. This finding can help design probiotic supplements
catering to a niche market defined by age, location, or disease
state.
From an Indian perspective, gut metagenomics have been stud-
ied in malnourished children (Gupta et al., 2011), obese indi-
viduals (Patil et al., 2012), and children of varying nutritional
status (Ghosh et al., 2014). It was for the first time in India
that the present study was conducted to investigate the elderly
gut metagenome to identify microbial biomarkers determining
responsiveness of the host to a probiotic therapy. We hypothe-
sized that by studying the baseline gut microbiota diversity of
elderly subjects, we could identify a core gut microbiome sig-
nature pattern that is likely to positively influence the response
of an individual to the probiotic strain. The strain under study,
Lactobacillus helveticus MTCC 5463 is an indigenous potential
probiotic with in vitro, in vivo, and in silico studies providing sug-
gestive evidences of the strain’s robustness in the gut and transit,
adhesion, autoaggregation, colonization, antibacterial property,
hypocholesterolemic, and immunomodulatory properties (Senan
et al., 2015). The outcome of this study paves the way forward for
tailored probiotic therapy.
Materials and Methods
Origin and Maintenance of Bacterial Strains
The indigenous probiotic strain L. helveticus MTCC 5463 (Pra-
japati et al., 2011) and starter culture Streptococcus thermophilus
MTCC 5460 (Prajapati et al., 2013) were maintained by the
Department of Dairy Microbiology, Anand Agricultural Univer-
sity, India at  80°C as 15% glycerol stocks and were routinely
cultured in de Man, Rogosa, Sharpe (MRS) and M 17 medium,
respectively (HiMedia India Ltd., India).
Product Preparation
The test product was a fermented probiotic drink (Lassi) with
double toned milk fermented with culture containing S. ther-
mophilusMTCC 5460 and L. helveticusMTCC 5463. The cultures
were added at 0.1% each and incubated aerobically till an acidity
of 0.8–0.9% lactic acid was obtained. Both the test and placebo
products contained sugar and prebiotic honey in a standardized
ratio. The control product was made in a similar manner without
the addition of MTCC 5463. The shelf life of the fermented drink
was 28 days at 4°C, corresponding to the lower level (109 CFU/ml)
of strain MTCC 5463.
Participant Selection
Individuals ranging from 64 to 74 years were recruited. Initially,
112 subjects were enrolled in the trial, 36 had to withdraw because
of antibiotic consumption. Volunteers were asked to sign the
consent form before recruitment. Exclusion criteria included lac-
tose intolerance, recent antibiotic treatment, frequent gastroin-
testinal disorders, or metabolic diseases. Participants included in
the trial had no known allergies or intolerance to dairy foods.
The trial had 80% power at a 5% 2-sided significance level to
detect a >50% change in the primary outcome among subjects.
No antibiotics or laxatives were taken 2months before or during
the study.
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Intervention
Sixteen participants showing diversity in lactobacilli count and
cholesterol levels were involved in the double-blind, crossover,
placebo-controlled, and randomized-feeding trial. The trial was
divided into five consecutive periods: a pre-feeding period
(2weeks), followed by a feeding period (4weeks), a washout
period (4weeks), a second-feeding period (4weeks), and a final
washout period (2weeks).
Collection and Analysis of the Blood Samples
Blood samples were taken from each volunteer immediately
before and after each treatment period using EDTA-containing
vacutainers. Total cholesterol (TC) was measured using enzyme-
spectrophotometry kits and IgG, IgM, TNF-alpha, INF-gamma,
and IL-2 by ELISA capture assay (Siemens Medical Solutions
Diagnostics Ltd., India). All the tests were done at the Central
Diagnostic Laboratory, Shri Krishna Medical College Karam-
sad, Anand, Gujarat, an NABL accredited and ISO 15189:2003
laboratory.
Selection of Respondents and Non-Respondents
A respondent was defined as a subject having an improvement
in the levels of L. helveticus MTCC 5463 strain count in feces
and a reduction in cholesterol levels. Similarly, a non-responder
was defined as a subject who displayed an absence of decrease
in cholesterol levels and increase in viability of the bacterial
strain. Based on these criteria, we identified eight subjects each
in respondents and non-respondents category.
Fecal Sample Collection
Single fecal samples were collected at the end of every 2weeks.
Participants were given 60ml sterile stool container with a sterile
plastic spoon (Polylab Plasticware, India) andwere asked to fill the
tube to the 30ml mark with feces from the midstream defecation
period. During the second-feeding period, there was a crossover
of the feeding design. For every collection, the stool samples were
immediately frozen at 20°C.
DNA Extraction from Stool Samples
DNA was extracted from feces using a QIAamp MiniPrep DNA
extraction kit following themanufacturer’s instructions. TheDNA
was stored at  20°C. Quality and purity of the isolated genomic
DNA were confirmed by agarose gel electrophoresis and spec-
trophotometry on the NanoDrop 2000 device (Fisher Scientific,
Schwerte, Germany). DNA concentration was estimated with the
Qubit 2.0 instruments applying the Qubit dsDNA HS Assay (Life
Technologies, Invitrogen division, Darmstadt, Germany).
Quantification of Lactobacilli in Stool
The subjects voided their feces into a 60-ml sterile stool con-
tainer with a sterile plastic spoon (Polylab Plasticware, India)
from the midstream defecation period. Within an hour of sample
procurement, samples were diluted and homogenized to give a
10-fold dilution (wet weight/volume). Stool Lactobacilli content
was determined by plating aliquots (1ml) of each dilution on
freshly prepared de Mann Rogosa Sharp agar (Himedia, India),
incubated for 24–48 h at 37°C under anaerobic conditions. Stool
L. helveticusMTCC 5463 content was determined by quantitative
PCR (qPCR) using StepOneReal-TimePCRSystem (ABI/Thermo
Fisher Scientific, Bangalore, India). Primers and 30 minor groove
binder (MGB) probes for accurate detection and quantification
of L. helveticus MTCC 5463 in human fecal samples were devel-
oped with Primer Express v3.0 [Thermo Fisher Scientific (earlier
Applied Biosystems), Bangalore, India]. The temperature profile
of the qPCR consisted 2min at 50°C, 10min at 95°C, followed
by 45 cycles of 15 s at 95°C, and 1min at 60°C. Species specific
primers and probe targeted on the bile salt hydrolase gene ofL. hel-
veticusMTCC 5463 (Accession number AEYL01000315; locus tag
AAULH_13111 2049 bp). BLAST1 andEMBL2 databasewere used
to ensure the specificity of the primers. Genomic DNA standards
prepared with six different serial dilutions (2.68 106, 2.68 105,
2.68 104, 2.68 103, 2.68 102, and 2.68 10) being equivalent
to ranges from106 to 101 CFU/ml of target genome (MTCC5463).
The cycle threshold (CT) was evaluated to create the standard
curve. The amplification efficiencies were determined using the
formula E= [10( 1/slope)  1].
16S Primers and Amplicon Library Generation
PCR amplification of the 16S rRNA hypervariable region V2–V3
was performed with a pool of 32 degenerated forward and 1
degenerated reverse primer targeting bacteria as described by
Schmalenberger et al. (2001) with barcode sequences at the 50
end of the primers. Primers were assessed for specificity using the
SILVA 108 SSU Reference 16S rRNA gene database and BLASTN
matches with corresponding 16S rRNA gene sequences. The addi-
tion of the barcodes to the primers resulted in an amplicon approx-
imately 430 nt in length. The primers were diluted and pooled to
equimolar quantities. For amplicon library preparation, 4 ng of
each genomicDNA, 5mMdNTPs, 2mMMgCl2 (RocheDiagnos-
tics, USA), 1U Platinum Taq DNA polymerase High Fidelity, and
10 pmol primer-mix were used per 25μl amplification reaction.
The PCR conditions were as follows: 95°C for 5min, followed
by 30 cycles of 94°C for 15 s, 60°C for 45 s, 70°C for 30 s, and
a final elongation step of 72°C for 10min. Amplicon product
purification was performed via gel electrophoresis on a 1.5% Tris
Borat EDTA agarose gel-stained with ethidium bromide (EtBr)
(Life Technologies). All positive PCR reactions were electrophore-
sized in agarose gels and products with the expected size were cut
and purified with Qiagen Gel extraction kit (Qiagen, Düsseldorf,
Germany). The exact fragment sizes were determined using HT
DNA High Sensitivity LabChip Kit (Caliper Life Sciences GmbH,
Mainz, Germany). Amplicon library concentration was estimated
with the Qubit 2.0 instrument using the Qubit dsDNA HS assay
(Life Technologies).
Emulsion PCR and Sequencing
The emulsion PCR was carried out applying the Ion XPress Tem-
plate kit V2.0 (Life Technologies) as described in the appropri-
ate user Guide (Part No. 4469004 Rev. B 07/2011) provided by
the manufacturer. Quality and quantity of the enriched spheres
were checked on the Guava easyCyte5 system (Millipore GmbH,
1http://www.ncbi.nlm.nih.gov/blast/
2http://www.ebi.ac.uk/embl/
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Schwalbach am Taunus, Germany) as described in the appendix
of the Ion Xpress Template Kit User Guide (Part Number 4467389
Rev. B, 05/2011). Sequencing of the amplicon libraries was car-
ried out on the Ion Torrent Personal Genome Machine (PGM)
system using the Ion Sequencing 200 kit (all Life Technolo-
gies) following the corresponding protocol (Part No. 4471999
Rev B, October 13, 2011). Quality check passed libraries were
subjected to emulsion PCR using the Ion PGM 200 Xpress
Template Kit (Life Technologies). After bead enrichment, beads
were loaded onto Ion 316 chips and sequenced using an Ion
Torrent PGM.
Sequence Analysis
The sequence data sets obtained were uploaded to the
Metagenome Rapid Annotation using Subsystem Technology
(MG-RAST) server3 and subsequently checked for low-quality
reads. The sequence reads that passed the quality filtering step
were then subjected to further analysis of the taxonomic annota-
tion of the fecal DNA sequences using QIIME pipeline (Caporaso
et al., 2010). To investigate the species diversity, we used
rarefaction curves, and richness estimators like Chao1 in QIIME.
Statistic comparison of samples organized into respondents
and non-respondents for the deferentially abundant microbial
diversity was studied using an alignment platform, STAMP.4
Results
We conducted a comparative analysis of respondents and non-
respondents fecal microbiome to reveal differences and identified
biomarkers that differentiate them.
Quantification of Lactobacilli Count Using
Traditional Plating and qPCR
Traditional plate counts of lactobacilli at genus level on selective
medium ranged from a baseline reading of 8.6 logCFU/g of wet
fecal matter, which rose to 9.3 log CFU/g at the end of feeding
period and a gradual decrease to 8.7 log CFU/g at the end of the
placebo feeding. The qPCRprimers targeted the bile salt hydrolase
gene ofMTCC5463, whichmade the gene copy count a fraction of
the plate count. On the other hand, the precise L. helveticusMTCC
5463 strain count from real-time PCR showed a complete absence
of the strain before feeding. At the end of 30 days, the strain
appeared in the feces of all subjects in the treated group, reaching a
level as high as 8.32 to the lowest amount of 6.17 log gene copies/g
fecal matter at end of feeding period.
Summary of Sequence Processing Data
Primers targeting the 16S rRNA gene V2–V3 region (Schmalen-
berger et al., 2001) precisely generated amplicons from members
of the domain bacteria and did not hybridize to sequences of
the domains Archaea and Eucarya. By using the ARB SILVA 108
SSU database, a high match of 84.5% at a maximum number
of four mismatches was observed. The primer pair theoretically
targeted all 16S rRNA gene sequences of the gut microbiota bac-
terial orders and generated a single amplicon. All 32 amplicons
3http://metagenomics.nmpdr.org/
4http://kiwi.cs.dal.ca/Software/STAMP
from the pool of test and placebo groups were mixed together
at an equimolar ratio. After pooling and elution of the ampli-
cons from the gel, we got one band for the probiotic fed group
of 520 bp having a concentration of 1912.09 pg/μl and molarity
of 5562.5 pmol/l. The placebo fed group gave an amplicon of
513 bp having a concentration of 1435.87 pg/μl and 4237.7 pmol/l
molarity. The data sets for 16 subjects before probiotic feeding
had reads ranging from 13,061 to 980,628 with a read length
ranging from 201 to 251 bp and a total amount of 42,52,62,470
bases.
Inter-Individual Differences in Shifts in Phyla
Abundance (%) Before and After Probiotic
Feeding
The relative abundance of major genera in the elderly gut
metagenome and high-level of inter-individual variation is shown
in Figure 1. We presume that the inter-individual differences are
indicative of a highly personal fecal microbiota profile, which
determines the response of the host to probiotics. Host factors
probably play a major effect in shaping the intestinal micro-
bial ecosystem during an intervention. In the present study, we
attempted to understand the core microbiome of respondents and
non-respondents to probiotics.
Probiotic Feeding and Effect on Lipid Profile and
Immunologic Parameters
In addition to TC (primary outcome), in this study, we also
investigated the effect of probiotic intervention on lipid profile,
beta glucouronidase activity, and immunological parameters. The
mean β-glucuronidase activity was reduced in test group from
1.40 to 0.73 (microgram/min/mg of protein), while in case of
placebo group, no effect on enzyme activity was observed. A
significant immunomodulatory effect on the TNF-α and IL-2
levels in subjects among probiotic group compared to placebo
group was observed. There was however no significant ben-
eficiary effect found on IFN-γ, IgG, or IgM levels. Paired t-
test showed that there were statistically significant differences in
serum cholesterol, VLDL, TC/HDL, LDL/HDL in placebo group
and in LDL, TC/HDL, and LDL/HDL in probiotic group. A signif-
icant (p= 0.01) decrease in the LDLvaluewas seen in the probiotic
group at the end of 30 days of feeding (Table 1).
Participant Diversification into Respondents and
Non-Respondents
The primary outcome of this trial was a reduction in TC after
4weeks of feeding probiotic MTCC 5463. We defined non-
respondents as those subjects who experienced elevations in
TC of 2.509mg/dL, whereas respondents were the ones who
showed no change in TC or <1.72mg/dL TC in response to
the probiotic intervention of 4weeks. Among the 59 subjects
who could complete the study, we classified a total of 16 sub-
jects into respondents (n= 8) and non-respondents (n= 8) based
on cholesterol levels and lactobacilli counts (Figure 2). There
were no significant differences in the baseline characteristics of
the two groups. This eliminates the influence of gender, weight,
and age in influencing the response toward probiotic interven-
tion. The abundance of L. helveticus MTCC 5463 was significant
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FIGURE 1 | Inter-individual variation in the geriatric gut microbiome pre- and post-probiotic feeding.
TABLE 1 | Effect of probiotic and placebo interventions on lipid profile in
geriatric subjects.
Variables Probiotic
(means SD)
Placebo
(means SD)
Total cholesterol (TC) (mg/dL)
Baseline 161.6741.05 174.3249.99
Post-intervention 158.0942.63 167.0943.11
p-Value 0.12 <0.001
Triglyceride (mg/dL)
Baseline 103.7749.84 116.3871.01
Post-intervention 104.0056.43 108.5870.74
p-Value 0.96 0.03
High density lipoprotein (HDL) (mg/dL)
Baseline 46.2112.46 49.6715.97
Post-intervention 47.0813.97 48.7712.98
p-Value 0.24 0.34
Low density lipoprotein (LDL) (mg/dL)
Baseline 98.4837.12 88.9338.37
Post-intervention 92.9335.79 84.5631.13
p-Value 0.01 0.09
Very low density lipoprotein (mg/dL)
Baseline 21.6312.04 23.2814.20
Post-intervention 21.3411.97 21.7114.12
p-Value 0.74 0.03
Total cholesterol/HDL (mg/dL)
Baseline 3.911.22 3.771.33
Post-intervention 3.741.20 3.651.23
p-Value <0.001 0.04
LDL/HDL (mg/dL)
Baseline 2.370.96 2.231.01
Post-intervention 2.210.91 2.130.96
p-Value <0.001 0.04
(p< 0.05) higher in the individuals with an increase in cholesterol
levels, as compared to those with a decrease. The decrease in
cholesterol levels among respondents was a maximum 14.19%
with a 23.66% increase in lactobacilli count in feces. Among
non-respondents, a maximum increase of 34.13% in cholesterol
with a 9.31% decrease in lactobacilli count was observed. The
increase in lactobacilli counts with a decrease in cholesterol in case
of respondents indicated that the observed hypocholesterolemic
effect of the strain was dependent on the number of lactobacilli in
the gut.
Microbiome Diversity Estimates Associated with
Respondents and Non-Respondents
The alpha diversity of the respondent group before probiotic
feeding (30.8 4.8) and after feeding (26.6 3.6) was higher
than non-respondents’ measures for before (25.6 4.5) and after
probiotic feeding (24.6 5.8). This indicates that bacterial rich-
ness is a factor that promotes responsiveness toward beneficial
strains in the gut. To investigate differences in rarefaction mea-
sures, we rarified each sample at 33,000 reads and performed the
two-sample t-test on the two groups. Respondents had signifi-
cantly greater alpha diversity indices like phylogenetic distance
(p= 0.022), Chao1 (p= 0.019), and Shannon index (p= 0.00058)
than the non-respondents (Figure 3). A non-significant increase
in observed species in case of non-respondents (p= 0.27) could
be due to presence of distinct commensals that reflect the host’s
dietary and geographical differences. There was a non-significant
abundance of Clostridium, Shigella, and Listeria among rural
respondents. Poor sanitation and hygiene maintained in the rural
households could have led to the distinct differences in gut
microbiota.
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FIGURE 2 | Comparison of response groups with respect to (A) lactobacilli counts and (B) cholesterol levels. The middle line represents the median, the
box represents the interquartile range, and the whiskers represent the total range.
Bacterial Taxa Populations Associated with
Respondents and Non-Respondents
We performed a comparison of the microbiota between
respondents and non-respondents to find specialized
bacterial members within the abundant phyla Firmicutes
and Proteobacteria. Respondents carried a lower proportion of
Clostridium and a higher proportion of Eubacterium compared
to the non-respondents (Figure 4). Surprisingly, although the
non-respondents had a higher proportion of gut lactobacilli
(31%) compared to 28% in respondents, a favorable reduction in
cholesterol corresponding to the increase in strain MTCC 5463
was not observed. This could be due to competitive exclusion
by a higher proportion of Clostridium (24%) in the gut on
non-respondents compared to respondents (6%). The presence
of Listeria in the non-respondents further emphasizes the
need to investigate the association of gut microbiota, especially
pathobionts with probiotic strain. Comparing the abundance in
the genera of Proteobacteria group, it can be observed (Figure 5)
that respondents carried a higher amount of Burkholderia
(63%) and a lower amount of Shigella (7%) compared to non-
respondents, who harbored lower count of Burkholderia (36%)
and a higher amount of Shigella (31%), which must have affected
the colonization of the probiotic strain. Non-respondents carried
a higher amount of Escherichia and Brucella in the gut. Shigella
seemed to have a symbiont asymptomatic existence in the host,
showing no discomfort to the subjects. The higher amount of
Escherichia andCamphylobacter could be the deciding biomarkers
of non-responsiveness toward probiotic intervention.
Statistical Analysis of Metagenomic Data
A remarkable significant difference among the chief genera of
Proteobacteria including Shigella, Escherichia, Burkholderia, and
Camphylobacter (q< 0.002) was observed. The chief genera of
Firmicutes that showed remarkable significant difference were
Lactobacillus, Clostridium, Eubacterium, and Blautia (q< 0.002)
(Figure 6). Although non-respondents carried a higher pro-
portion of Lactobacilli, a favorable physiological function may
not be translated to the host possibly due to an increase in
Clostidum, Shigella, andEschericihiawith a decrease inBlautia and
Burkholderia. We would like to add that the results of population
wide samples taken at one time point for a studymight not be able
to display the entire variation that exists in that population over
time and place.
Discussion
Aprimary beneficial effect of consuming a bile-salt-hydrolyzingL.
helveticus MTCC 5463 strain is a reduction in serum cholesterol
levels. In the clinical trials carried out to prove the hypocholes-
terolemic effect of the strain (Ashar and Prajapati, 2001; Prajapati
et al., 2012) we could observe participants responding differently
to the same treatment. Similar cases of inter-individual variability
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FIGURE 3 | Estimation of the phylogenetic diversity of the gut microbiota in the respondent and non-respondent groups using the (A) Shannon index,
(B) phylogenetic distance, (C) Chao1, and (D) observed species. The values are means, and error bars indicate the 95% confidence intervals.
FIGURE 4 | Relative abundances of the dominant genera (Firmicutes) in (A) respondents and (B) non-respondents.
in response to probiotics (van Baarlen et al., 2011; Grzeskowiak
et al., 2012; Arboleya et al., 2013) have been published. Previously,
subjects had been classified as respondents and non-respondents
based on a greater than or less than 10% change in cholesterol
(Cox et al., 2014) but this classification was criticized as being
impractical (Ding and Schloss, 2014). Classification using a fecal
biomarker (Coen et al., 2009) or biomarkers of the host’s basic
metabolism (Naruszewicz et al., 2002; Herron et al., 2003; Ibrahim
et al., 2010) has been suggested.We conducted a comparative anal-
ysis of fecal microbiomes of respondents and non-respondents to
identify bacterial biomarkers. Results of such microbial profiling
may serve as a clinically useful biomarker in geriatric care (Kostic
et al., 2013).
Primer usage is one of the most critical factors affecting 16S
rDNA analysis (Armougom and Raoult, 2009). There exists a
possibility that amplification efficacy of the primers could have
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FIGURE 5 | Relative abundances of the dominant genera (Proteobacteria) in (A) respondents and (B) non-respondents.
FIGURE 6 | Analysis of significance in abundance of (A) Firmicutes and (B) Proteobacteria among respondents and non-respondents using
two-sample Fischer’s exact test.
led to the underestimation of bacterial richness, in this study. We
chose the Ion Torrent PGM platform due to its inherent low-cost
per sequencing run that allowedus to perform the next-generation
sequencing on site at the Veterinary faculty at AAU.
There were no significant differences in the age or weight of
respondents and non-respondents, though respondents had a ten-
dency to be older. An effect size of 0.8 among the groups further
eliminated the influence of gender, weight, and age toward the
expected response. Grouping of similar sequences as operational
taxonomic units (OTUs) and quantifying the number of OTUs
gave an approximation of species diversity in a sample (Sun et al.,
2009; Schloss et al., 2014). Species diversity has been reported
as a characteristic feature determining state of health or disease.
Reduced colonic microbial diversity of dysbiosis is reported in
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Crohn disease (Ott et al., 2004), ulcerative colitis (McLaughlin
et al., 2010), antibiotic-associated diarrhea (Chang et al., 2008),
and Clostridium difficile infection (Seto et al., 2014). A higher
alpha diversity of gut bacteria among respondents compared to
non-respondents seemed to support microbial integrity. Bacterial
richness and evenness play an integral role in the success of a
probiotic therapy as earlier observed in colitis (Kennedy et al.,
2000).
A higher Chao’s estimator and the Shannon index among
respondents indicate higher saturation and unevenness in taxa
abundancewithin samples. Anon-significant increase in observed
species in case of non-respondents suggested the presence of
species that may have prevented the probiotic to establish and
exert the functionality. We could identify distinct microbial diver-
sity in rural subjects compared to the urban dwellers especially
in the presence of Clostridium, Shigella, and Listeria, similar to
Russian rural communities (Tyakht et al., 2013). Gram-negative
bacteria were more abundant than Gram-positive bacteria in
the rural population. Shigella and Escherichia were significantly
under-represented in rural African children than urban European
children (De Filippo et al., 2010). In the present study, we observed
Shigella and Escherichia higher in geriatric rural dwellers, which
reflected the age and geography-induced diversities in human gut
microbiome.
Phyla associated with a healthy state in Indian geriatrics as
suggested in this study are Firmicutes accounting for at least
50%, followed by Actinobacteria (20%) and Proteobacteria (10%).
At the phylum level, the majority of the intestinal bacteria are
known to belong to Bacteroidetes and Firmicutes (Eckburg et al.,
2005). Surprisingly, none of the sequences from the present study
were assigned to the Bacteroidetes. An under representation of
Bacteroidetes could be due to inter-subject variability (Ley et al.,
2006), variation due to adiposity (Frank et al., 2007; Wu et al.,
2011), or suppression due to inflammatory bowel disease (Lazare-
vic et al., 2009). We could not ignore the possibility of loss of this
phylum in fecal samples when stored for longer periods and MG-
RAST-based classifications’ sensitivity for Proteobacteria (Kor-
pela et al., 2014). Antibiotic usage in elderly can again cause a
decline in commensal anaerobes like Bacteroides, Lactobacillus,
and Bifidobacterium (Macfarlane, 2014).
Responses of the host to individual bacterial strains are
influenced by the baseline composition of the gut microbiota
(Rajilić-Stojanović et al., 2015). The respondents showed a lower
percentage of Firmicutes and non-respondents showed a com-
parative lower amount of Proteobacteria. Among Firmicutes,
Clostridia were higher in case of non-respondents (24% compared
to 6% in respondents). Although the volunteers were not consum-
ing antibiotics during the trial, prior usage of antibiotics could
have diminished the population of total and commensal bacte-
ria (Biagi et al., 2010) leading to an overgrowth of Clostridium
(Round and Mazmanian, 2009) in non-respondents. Antibiotics
are readily available over the counter at pharmacies in India and
inconsistent hospital standards toward antibiotic usage could have
led to higher proportion of Clostridia in the gut. Respondents
carried a higher proportion of Eubacterium (28% compared to
12% in non-respondents), which reflected a healthy state. An
increased diversity of Eubacteria has been observed in the elderly
(Hopkins and Macfarlane, 2002). Decrease in Eubacterium lead
to decreased levels of SCFA, facilitating easier entry of Enterobac-
teriaceae into the intestinal mucosa due to an impaired secretion
of mucins by the intestinal epithelial cells (Garrett et al., 2010).
The outgrowth of anaerobic Enterobacteriaceaemust have led to a
competitive exclusion of aerotolerant MTCC 55463 strains in the
host intestine.
Proteobacteria, recently defined as “pathobionts” (Morgan
et al., 2004) are considered to be minor and opportunistic
components of the human gut ecosystem. The majority of the
sequences assigned to the Proteobacteria were Burkholderiales.
A higher proportion of Burkholderia is a signature of good
health as earlier observed in the healthy Indian child data set
(Schultz et al., 2004). Non-respondents had a higher proportion of
Proteobacteria, especially Escherichia/Shigella (indistinguishable
as a 16S-based phylotype), previously implicated in intestinal
inflammation (Guslandi et al., 2004). Although the volunteers
were seemingly healthy with no complaints of gastrointestinal
disturbances, a core structural and functional dysbiosis caused
by an overgrowth of Escherichia/Shigella (Malchow, 1997) could
have led to a lack of translation of functionality of MTCC 5463
to the host in spite of being present at a higher proportion in the
non-respondents gut.
In this study, it was shown that consumption of probiotic
yogurt did not significantly reduce TC levels, the intervention
significantly reduced serum levels of LDL, TC/HDL ratio, and
LDL/HDL ratio in geriatric volunteers. Many studies in literature
support the beneficiary effect of probiotics on lipid profiles of
subjects. There also exist some contradictory reports where eating
probiotic yogurt did not change lipid profiles (Hatakka et al., 2008;
Sadrzadeh-Yeganeh et al., 2010). This indicates that apart from the
probiotic strain, the host gut microbiome has a big role to play on
the response of the host to the probiotic strain.
STAMP analysis revealed proportions of distinct microbial
biomarkers like Shigella, Escherichia, Burkholderia, Camphylobac-
ter, Lactobacillus, Clostridium, Eubacterium, and Blautia that can
help tailor a probiotic therapy to a niche population. The authors
would like to strike an analogy to feeding probiotics to a host
with imbalanced consortia in the gut to the likes of pouring
water to a filled pitcher. Like the water flows out, the probiotic
strains are lost in the feces and fail to colonize and translate
the functionality to the host. Metatranscriptomic studies could
furnish further information for comprehending the molecular
basis of responsiveness toward a probiotic therapy because gene
expression profiles are more individualized than DNA-level pro-
files and less variable than microbial composition. Geriatric care
is critical in the aging global population and the role of gut
metagenomics cannot be overstated in understanding its role in
health and disease for the future development of personalized
nutrition.
Conclusion
Globally today, the elderly populations are looking for natural
means of sustaining digestive health. Compared to the grow-
ing awareness and market penetration of probiotics, there is
a dearth of scientific evidence on how probiotics affect the
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composition of gut microbiota. The well-documented probiotic L.
helveticusMTCC 5463 was administered to geriatrics in a clinical
trial, and a deep sequencing technologywas employed to study the
changes in the resident microbes over the duration of probiotic
consumption. We could find that chiefly Shigella, Escherichia,
Burkholderia, Camphylobacter, Lactobacillus, Clostridium, Eubac-
terium, and Blautia define the response of the host to the probiotic
strain. Moreover, we observed a shift in the gut profile of the
non-respondents towards a respondent’s signature gut profile after
consuming the probiotic, which proves the importance of precise
personalized selection of dosage for an effective tailored probiotic
therapy.
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